MeiraGTx Holdings (MGTX) Share-based Compensation (2017 - 2025)
MeiraGTx Holdings posted quarterly Share-based Compensation of $5.6 million for Q4 2025, down 8.44% year-on-year from $6.1 million in Q4 2024, and down 5.9% on a QoQ basis from $6.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Share-based Compensation data on file, last reported at $5.6 million in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation fell 8.44% year-over-year to $5.6 million; the trailing twelve-month figure through Dec 2025 stood at $22.1 million (down 12.24% YoY), and the FY2025 full-year result was $22.1 million, down 12.25% from the prior year.
- Share-based Compensation for Q4 2025 stood at $5.6 million, down from $6.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.6 million in Q1 2022 and bottomed at $4.8 million in Q1 2021.
- The 5-year median for Share-based Compensation is $6.2 million (2024), against an average of $6.2 million.
- The widest annual swing landed in 2022, when Share-based Compensation surged 57.32%; it then fell 29.78% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $5.4 million in 2021, then climbed by 25.44% to $6.8 million in 2022, then grew by 2.28% to $7.0 million in 2023, then slipped by 12.11% to $6.1 million in 2024, then fell by 8.44% to $5.6 million in 2025.
- The last three Share-based Compensation figures came in at $5.6 million (Q4 2025), $6.0 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.60 Mn |
| Dec 31, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.95 Mn |
| Sep 30, 2025 | 5.95 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 4.89 Mn |
| Mar 31, 2025 | 4.89 Mn |
| Dec 31, 2024 | 6.12 Mn |
| Dec 31, 2024 | 6.12 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 6.96 Mn |
| Mar 31, 2024 | 6.96 Mn |
| Dec 31, 2023 | 6.96 Mn |
| Dec 31, 2023 | 6.96 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Sep 30, 2022 | 6.94 Mn |
| Sep 30, 2022 | 6.94 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Mar 31, 2022 | 7.58 Mn |
| Mar 31, 2022 | 7.58 Mn |
| Dec 31, 2021 | 5.43 Mn |
| Dec 31, 2021 | 5.43 Mn |
| Sep 30, 2021 | 5.34 Mn |
| Sep 30, 2021 | 5.34 Mn |
| Jun 30, 2021 | 5.20 Mn |
| Jun 30, 2021 | 5.20 Mn |
| Mar 31, 2021 | 4.82 Mn |
| Mar 31, 2021 | 4.82 Mn |
| Dec 31, 2020 | 3.94 Mn |
| Dec 31, 2020 | 3.94 Mn |
| Sep 30, 2020 | 3.74 Mn |
| Sep 30, 2020 | 3.74 Mn |
| Jun 30, 2020 | 5.06 Mn |
| Jun 30, 2020 | 5.06 Mn |
| Mar 31, 2020 | 5.68 Mn |
| Mar 31, 2020 | 5.68 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Sep 30, 2019 | 3.51 Mn |
| Sep 30, 2019 | 3.51 Mn |
| Jun 30, 2019 | 4.39 Mn |
| Jun 30, 2019 | 4.39 Mn |
| Mar 31, 2019 | 2.93 Mn |
| Mar 31, 2019 | 2.93 Mn |
| Dec 31, 2018 | 2.33 Mn |
| Dec 31, 2018 | 2.33 Mn |
| Sep 30, 2018 | 3.41 Mn |
| Sep 30, 2018 | 3.41 Mn |
| Jun 30, 2018 | 6.53 Mn |
| Jun 30, 2018 | 6.53 Mn |
| Mar 31, 2018 | 4.28 Mn |
| Mar 31, 2018 | 4.28 Mn |
| Dec 31, 2017 | -2.03 Mn |
| Dec 31, 2017 | -2.03 Mn |
| Sep 30, 2017 | 508,833.00 |
| Sep 30, 2017 | 508,833.00 |
| Jun 30, 2017 | 682,135.00 |
| Jun 30, 2017 | 682,135.00 |